Remove mHealth Remove Mobile Health Remove Telehealth Remove Tips
article thumbnail

Survey: U.S. Health System Leaders Embracing Remote & Virtual Care

care innovations

Commonly even those health systems that do receive reimbursement for virtual care and/or telehealth report the rate is much lower than what they would receive for inpatient services or primary care visits ,” the report authors note. Telehealth] gives a better consumer experience.”. To lower costs (46%).

article thumbnail

Five Ways Digital Technologies can Address Cancer

The Digital Health Corner

Connected care: apps: Connected care today includes such technologies as wearables and mobile health apps. Three impressive mobile apps in the oncology space are: a. Benefits of connected care include triangulating the transmission of information (among clinicians, patients and caregivers), convenience, and timeliness.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nudging Patients to Use EHRs: Moving Toward a Tipping Point for Consumer Health IT

Health Populi

Patients have plenty of reason to be concerned; the healthcare industry must work harder to build trust, policies and procedures, and secure tech into health data programs. The post Nudging Patients to Use EHRs: Moving Toward a Tipping Point for Consumer Health IT appeared first on HealthPopuli.com.

EHR 203
article thumbnail

Why It's Time to Embrace Telemedicine

eVisit

What’s this new thing called Telemedicine? For starters, it’s not new! I t’s more than 40 years old and was developed as a way to use improvements in communication technology to bring quality medical diagnoses and care to individuals in remote parts of the world.

article thumbnail

Five Ways a Good Digital Health Registry Addresses Healthcare System Needs

The Digital Health Corner

This might tip the benefit-cost ratio for payers to support a drug or other treatment’s cost. Post-marketing patient registries which provide patient reported outcomes could significantly lower drug costs by providing data showing better efficacy than the approval studies.